News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
828,099 Results
Type
Article (83156)
Company Profile (433)
Press Release (744486)
Multimedia
Podcasts (210)
Webinars (32)
Section
Business (217574)
Career Advice (3591)
Deals (38251)
Drug Delivery (163)
Drug Development (90056)
Employer Resources (195)
FDA (18197)
Job Trends (16755)
News (377170)
Policy (38634)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3027)
Academic (2)
Accelerated approval (45)
Adcomms (37)
Allergies (173)
Alliances (54902)
ALS (207)
Alzheimer's disease (1885)
Antibody-drug conjugate (ADC) (415)
Approvals (18429)
Artificial intelligence (701)
Autoimmune disease (249)
Automation (53)
Bankruptcy (388)
Best Places to Work (12499)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (292)
Bladder cancer (186)
Brain cancer (73)
Breast cancer (730)
Cancer (5662)
Cardiovascular disease (503)
Career advice (3076)
Career pathing (46)
CAR-T (331)
CDC (71)
Celiac Disease (2)
Cell therapy (901)
Cervical cancer (43)
Clinical research (76709)
Collaboration (2080)
Company closure (7)
Compensation (1313)
Complete response letters (91)
COVID-19 (3009)
CRISPR (110)
C-suite (1054)
Cystic fibrosis (159)
Data (7249)
Decentralized trials (3)
Denatured (75)
Depression (176)
Dermatology (59)
Diabetes (590)
Diagnostics (7355)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (346)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (91238)
Editorial (71)
Employer branding (25)
Employer resources (168)
Events (127280)
Executive appointments (1111)
FDA (21760)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1734)
Gene editing (238)
Generative AI (69)
Gene therapy (748)
GLP-1 (1206)
Government (5450)
Grass and pollen (8)
Guidances (400)
Healthcare (20874)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (92)
Indications (158)
Infectious disease (3353)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (283)
Interviews (685)
IPO (17628)
IRA (61)
Job creations (4613)
Job search strategy (2488)
JPM (73)
Kidney cancer (19)
Labor market (98)
Layoffs (668)
Leadership (45)
Legal (9689)
Liver cancer (106)
Longevity (29)
Lung cancer (759)
Lymphoma (417)
Machine learning (54)
Management (65)
Manufacturing (1004)
MASH (194)
Medical device (14978)
Medtech (15059)
Mergers & acquisitions (21812)
Metabolic disorders (1588)
mRNA (215)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (436)
Neuropsychiatric disorders (116)
Neuroscience (3412)
Neurotech (2)
NextGen: Class of 2026 (7500)
Non-profit (5115)
Now hiring (72)
Obesity (778)
Opinion (355)
Ovarian cancer (190)
Pain (248)
Pancreatic cancer (268)
Parkinson's disease (364)
Partnered (38)
Patents (583)
Patient recruitment (620)
Peanut (65)
People (64438)
Pharmaceutical (86)
Pharmacy benefit managers (36)
Phase 1 (23638)
Phase 2 (33349)
Phase 3 (25156)
Pipeline (7322)
Policy (367)
Postmarket research (3450)
Preclinical (10548)
Press Release (69)
Prostate cancer (291)
Psychedelics (61)
Radiopharmaceuticals (329)
Rare diseases (1114)
Real estate (6953)
Recruiting (81)
Regulatory (28823)
Reports (62)
Research institute (2739)
Resumes & cover letters (576)
Rett syndrome (33)
RNA editing (22)
RSV (94)
Schizophrenia (178)
Series A (292)
Series B (214)
Service/supplier (18)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (51)
Startups (4132)
State (2)
Stomach cancer (21)
Supply chain (129)
Tariffs (102)
The Weekly (132)
Vaccines (1226)
Venture capital (111)
Weight loss (529)
Women's health (116)
Worklife (23)
Date
Last 7 days (678)
Last 30 days (2682)
Last 365 days (32167)
2026 (8582)
2025 (32536)
2024 (37445)
2023 (42320)
2022 (53673)
2021 (58420)
2020 (57354)
2019 (50988)
2018 (38837)
2017 (36557)
2016 (36991)
2015 (42681)
2014 (36831)
2013 (34141)
2012 (35063)
2011 (35098)
2010 (34640)
Location
Africa (1170)
Alabama (99)
Alaska (7)
Arizona (341)
Arkansas (15)
Asia (49224)
Australia (8586)
California (12656)
Canada (3592)
China (1334)
Colorado (537)
Connecticut (552)
Delaware (382)
Europe (114632)
Florida (1899)
Georgia (409)
Hawaii (4)
Idaho (69)
Illinois (1059)
India (87)
Indiana (583)
Iowa (23)
Japan (505)
Kansas (137)
Kentucky (47)
Louisiana (44)
Maine (85)
Maryland (1567)
Massachusetts (9237)
Michigan (375)
Minnesota (717)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (29)
Nevada (142)
New Hampshire (90)
New Jersey (3409)
New Mexico (33)
New York (3364)
North Carolina (1703)
North Dakota (10)
Northern California (6211)
Ohio (389)
Oklahoma (25)
Oregon (46)
Pennsylvania (2543)
Puerto Rico (27)
Rhode Island (53)
South America (1560)
South Carolina (78)
South Dakota (1)
Southern California (4955)
Tennessee (205)
Texas (2022)
United States (45451)
Utah (383)
Vermont (1)
Virginia (319)
Washington D.C. (87)
Washington State (1037)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
828,099 Results for "st luke s roosevelt and continuum cancer centers".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum
December 4, 2025
·
6 min read
Press Releases
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
March 1, 2026
·
11 min read
Bladder cancer
Merck, Pfizer’s Drug Combo ‘Rewrites the Standard of Care’ in Bladder Cancer
A combination of Merck’s Keytruda and Pfizer’s Padcev could offer a chemotherapy-free treatment alternative for patients with muscle-invasive bladder cancer, even those eligible for cisplatin treatment.
March 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature
December 4, 2025
·
3 min read
Stomach cancer
Jazz’s Ziihera Shows ‘Practice-Changing’ Efficacy in Stomach Cancer
Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall survival signals ever reported in a type of gastroesophageal cancer.
January 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
December 29, 2025
·
4 min read
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
Solstice Oncology will gain an exclusive worldwide license to Harbour BioMed’s porustobrt, an anti-CTLA-4 antibody currently being studied for melanoma, colorectal cancer and other malignancies in China.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center
March 4, 2026
·
3 min read
Press Releases
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to implant FDA-approved novel defibrillation lead
February 3, 2026
·
2 min read
1 of 82,810
Next
